Orchid Cellmark Inc announces expansion of DNA analysis footprint across UK

Trading Markets.com
DNA testing services company Orchid Cellmark Inc (Nasdaq: ORCH | PowerRating) stated on Thursday the receipt of a total estimated annual contract valued at approximately USD1.2m under the latest National Forensic Procurement regional tender.

Comments are closed.